There's been a notable change in appetite for Carl Zeiss Meditec AG shares in the week since its yearly report, with the stock down 15% to €49.30. Revenues were €2.1b, approxi ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Carl Zeiss Meditec has strong fundamentals and growth potential. It has impressive free cash flow and rising shareholder ...

The broader Asia-Pacific region was also a weak spot, with organic growth in ophthalmology devices down 4.5% for the year, ...

EQS-News: Carl Zeiss Meditec AG / Key word (s): Annual Report/Annual Results Carl Zeiss Meditec closes fiscal year 2023/24 with slight decline in revenue- Adjusted EBIT forecast achieved 11.12.2024 ...

View Carl Zeiss Meditec AG (CZMWY) current and estimated P/E ratio data provided by Seeking Alpha.

It is hard to get excited after looking at Carl Zeiss Meditec's (ETR:AFX) recent performance, when its stock has... Carl Zeiss Meditec AG ( ETR:AFX ), might not be a large cap stock, but it received a ...

It is hard to get excited after looking at Carl Zeiss Meditec's (ETR:AFX) recent performance, when its stock has... Carl Zeiss Meditec AG ( ETR:AFX ), might not be a large cap stock, but it received a ...

It is hard to get excited after looking at Carl Zeiss Meditec's (ETR:AFX) recent performance, when its stock has... Carl Zeiss Meditec AG ( ETR:AFX ), might not be a large cap stock, but it received a ...

It is hard to get excited after looking at Carl Zeiss Meditec's (ETR:AFX) recent performance, when its stock has... Carl Zeiss Meditec AG ( ETR:AFX ), might not be a large cap stock, but it received a ...